• Breaking News

    Monday, May 11, 2020

    Stock Market - Building the best dividend portfolio - Part 2

    Stock Market - Building the best dividend portfolio - Part 2


    Building the best dividend portfolio - Part 2

    Posted: 11 May 2020 12:20 AM PDT

    • I'd like to share an approach that I took to come up with the best dividend portfolio.
    • As a result, I identified 21 dividend-paying stocks that I can invest in with confidence.
    • Investing is personal, so I'm sharing all the data that I collected so that you can also use the data to come up with a dividend portfolio that works best for you.

    https://themetareview.com/building-the-best-dividend-portfolio-part-2/

    submitted by /u/The-Meta-Review
    [link] [comments]

    Know Your SEC Forms: An SEC Filing Reference Guide for Traders and Investors

    Posted: 11 May 2020 01:44 PM PDT

    Sourced From here

    Big Takeaway: The SEC has RSS feeds that can automatically notify you of a company's filings the moment they are published. It is therefore easy to be the first to know. No need to pay for a service that does this for you.

    Overview: With the wide spread availability of trading applications there came a number of retail traders who dove into trading without knowing the power of reading and understanding company SEC filings. SEC filings can provide critical indicators ("indicators" not "guarantees") as to a companies past and future performance. These documents can be an essential tool in helping an investor gauge whether to buy or sell a security. The purpose of the following entry is to provide a brief introduction to some of the most pertinent SEC Forms.

    Why Read SEC Forms?: An important part of doing your due diligence on a company before you invest is checking out their most recent and historical SEC filings. These filings, if read and assessed properly with other market signals, may be a good indicator of a companies financial strength and institutional and insider confidence. For example, a microcap or smallcap trader will want to assess how long a company can remain financially viable without releasing another offering, or perhaps, assess at what price an investor may exercise a previously issued warrant. A midcap and largecap investor might want to know what institutions and insiders are buying, and to what extent a company is growing revenue. In short, learning to read and analyze SEC Forms (combined with other market conditions) will give you a competitive advantage as a trader.

    EDGAR: There are a number of ways an investor can look up company SEC filings. However if you want to go straight to the horses mouth you go to the SEC's Electronic Data Gathering, Analysis, and Retrieval system; otherwise known as "EDGAR." I recommend simply typing in the ticker of your choosing into the "Fast Search" feature. From there you can find all of a company's SEC filings. If you really wanted to get savvy you can see all of your companies SEC filings as they are instantly filed by using your favorite RSS feed app. That's how right! for your convenience the SEC has an RSS feature for practically anything you want to look for. That way you will be among the first to be alerted when a company you're tracking files with the SEC. And just to think there are websites that charge for this kind of alert feature! Like most alerting software, its just a rip off for something you can otherwise get for free.

    Continues HERE

    submitted by /u/Cicero1982
    [link] [comments]

    What are some books that helped you as a beginner in the stock market?

    Posted: 11 May 2020 01:47 PM PDT

    Sorry if this is the wrong place to post this.

    I'm thinking about getting started in the stock market but before I do I want to educate myself as much as possible. There's so much information out there – it's hard to know what to read. I'd like to ask you to share what books helped you when you were a beginner. Whether the topic was about mentality, strategy, mistakes, or not about investing – if it helped you become a better investor I'd like to know about it.

    Thank you very much for your time!

    Edit: Thank you everyone who responded I really appreciate it. You guys are awesome

    Edit 2: If it's not too much trouble - please tell me in what ways the book made you a better investor.

    submitted by /u/leedex
    [link] [comments]

    High-risk, High-reward: Allogene (ALLO) Could Double in Value, with Catalysts This Week

    Posted: 11 May 2020 07:21 PM PDT

    Summary: Allogene is a ~$4B market cap clinical stage biotech company developing allogeneic ('off the shelf') CAR-T therapies for hematologic cancers and solid tumor indications. Allogene was founded in 2018 by Arie Belldegrun and David Chang, who previously led Kite Pharma to the Yescarta approval and an $11.9 B acquisition by Gilead. While the current high price point presents risks, 2020 will be a critical year for Allogene with multiple early-stage readouts: this presents an opportunity to ride several key value inflection points over the next 6 - 12 months

    Key Takeaways

    • There is a lot to like about the experience the Allogene team brings to the table and the promise of their platform to address the clinical and commercial shortcomings of current marketed CAR-T therapies
    • Allogene plans to initiate an abbreviated P1 trial for ALLO-501A in 2Q20 to confirm the results of the ALLO-501 P1 ALPHA trial, results for which will be presented this month at ASCO, prior to potentially advancing ALLO-501A to pivotal P2 development
    • If the lead program in NHL (ALLO-501/ALLO-501A) is successful, that represents in the range of 100% upside using Kite Pharma, another CAR-T company, as an analogue
    • Kite Pharma was valued at $8.4B prior to the Gilead acquisition with a filed BLA in NHL for Yescarta, double what Allogene is trading at today: given a high PTRS for Allogene's program in NHL (rationale outlined below), this represents directionally where we would expect Allogene's value to land in the future
    • However, current market cap of >$4 B constrains achievable upside versus the downside risk if near-term value clinical catalysts go against our expectation

    We are taking a modest (1 - 2% of portfolio) position ahead of the two key clinical readouts on 5/13 and 5/29 given our expectation for positive P1 results for ALLO-501 (ALPHA trial) and the 2Q20 initiation of P1/P2 ALPHA2 trial for ALLO-501A based on the following:

    • Strong preliminary P1 safety and efficacy data was presented in 2018 by for UCART19 in ALL, which is the same molecular design as ALLO-501
    • ALLO-501/ALLO-501A target CD-19 in NHL patients, which is the same target as the approved CAR-T's Kymriah and Yescarta in an overlapping patient population (DLBCL, a subtype of NHL), defraying clinical risk
    • Allogene will be taking the dose-finding learnings from the ALPHA trial into the ALPHA2 trials for ALLO-501A, the next-generation construct and P2 candidate in NHL, a switchover that has been planned since before the ALPHA trial was initiated
    • In an earnings call on 05/06, Allogene CEO David Chang indicated that the abbreviated P1 portion of ALPHA2 is on track to begin 2Q20, ahead of a potential pivotal P2 portion
    • However, the current price point is somewhat overvalued, and thus does not support us taking a larger position given the potential downside is substantial and potential gains partially already baked in

    Key Stock Drivers:

    • High unmet clinical need: substantial need for accessible and efficacious therapies remains in NHL & other hematological malignancies given limited options for r/r patients and the time-consuming and burdensome process required for current CAR-Ts
    • 'Off the shelf' CAR-T therapies address shortcomings of current CAR-Ts: the approach would theoretically mitigate the manufacturing issues that continue to drag down the commercial potential of and patient access to existing autologous CAR-T's
    • Several critical near-term inflection points in 2020: ASCO poster abstract covering initial P1 data for ALLO-501 in r/r NHL (ALPHA trial) will be released on 05/13, with further data including additional patients presented on 5/29. These data will support the ALPHA2 P1 and potential pivotal P2 trial for ALLO-501A, their next-generation construct for NHL. Initial P1 data for ALLO-715 in r/r MM (UNIVERSAL trial) remains on track for 4Q20 despite impact of COVID-19
    • Experienced leadership team with track record of rapid development and regulatory success in cell therapy: CEO David Chang and Executive Chairman Arie Belldegrun were formerly CMO and CEO of Kite Pharma, respectively, and led Yescarta, one of two CAR-T's on market today, to FDA priority review prior to acquisition by Gilead for $11.9 B (29.4% premium over market close prior to announcement)
    • Clinical programs focus largely on proven targets: ALLO-501/ALLO-501A and UCART19 are anti-CD19 therapies, which is the same target as the approved autologous CAR-Ts Yescarta and Kymriah, which somewhat de-risks these programs. Additional targets in development include BCMA for MM (ALLO-715, including in combination with nirogacestat in collaboration with SpringWorks)
    • Preliminary UCART19 data offers additional validation of platform: preliminary pooled data from P1 trials in ALL indicated that 14/17 (82%) of patients receiving an anti-CD52 antibody during lymphodepletion achieved a complete response (CR/CRi). The anti-CD52 antibody serves to protect the allogeneic CAR-T's from being cleared by the body's immune system. ALLO-501, ALLO-501A, and ALLO-715 are all dosed with ALLO-647, Allogene's internally developed anti-CD52 antibody, creating a "window of persistence" during which the allogeneic CAR-T's can exert their therapeutic effect

    Key Stock Risks:

    • Value of pipeline programs heavily interdependent: Given the clinical stage therapies are rooted in the same technology platform, any issues that emerge from the ALPHA or UNIVERSAL trials could feasibly drag down the value of the entire pipeline. On the flipside, however, positive preliminary ALPHA data would likely have the reverse effect of increasing PTRS across the clinical-stage portfolio
    • Stock currently trading at / near 52 week high: While Allogene traded in the $18 - 20 range for the latter part of March, the price has rebounded steadily upwards and scraped against an all-time high today on just-shy of average volume, reflecting both the overall market rebound and likely enthusiasm from the market for the impending ASCO data. This suggests there is significant immediate downside if the data falls short of expectations on 5/13 and 5/29
    • Long-term competitive risk is substantial: While Allogene is a leader in the field, the next-generation CAR-T space is fairly crowded. In addition, Fate Therapeutics (market cap: $2.3 B) has a pipeline of iPSC-derived natural killer and T cell therapies for hematologic malignancies and solid tumors reaching the clinic. While Allogene is exploring the iPSC space as mentioned above, Fate Tx has reached the clinic already, which may provide them with a leg-up in the long-run

    Disclosure: We currently own shares of Allogene Therapeutics. This article expresses our own opinions, not Allogene's or any other party's opinion. We are not receiving compensation for this report. We do not have a business relationship with the company mentioned in this report.

    submitted by /u/boccherini-trader
    [link] [comments]

    Favorite stocks to swing that have been relatively consistent?

    Posted: 11 May 2020 04:32 PM PDT

    Hey everyone! Anyone have any favorite stocks to swing that have relatively quick and consistent low to high turnovers? BA seems to be pretty consistent and maybe Tesla seems to have some potential with the variety of news going on with it. Also there has been a lot of movement within the airlines and cruise lines but it always seems like a guess on a good time to enter for those. Just curious if you all had any favorites that have worked for you in the past. I usually just scan for some but wouldn't mind trying out some others

    submitted by /u/ucsbevan
    [link] [comments]

    Stock Watch List May 11, 2020

    Posted: 11 May 2020 05:43 AM PDT

    Good morning. Here's my watch list:

    Gap Ups: AMC, APOP, BLPH, CAH, CYTK, KC, MYOK, NVAX, QDEL, STNE, VTIQ

    Gap Downs: REPH

    Spy slightly gapping down inside of yesterdays range, getting some sideways action as price approaches resistance at the 200 day moving average. Not many stocks gapping pre market, we could be setting up for another inside day with tight range. Be patient, only take the best setups with stop and targets calculated before entering trades to ensure profits and eliminate unnecessary losses. Good luck trading today.

    submitted by /u/Kant_sleep13
    [link] [comments]

    The Great Monetary Inflation & the Future of Digital Money | Michael Casey

    Posted: 11 May 2020 11:13 AM PDT

    Listen to the full episode

    Demetri Kofinas speaks with CoinDesk Chief Content Officer Michael Casey about "The Great Monetary Inflation" and the future of digital money. The two chronicle the financialization of the global economy that occurred between the end of gold convertibility in 1971 and the Great Financial Crisis of 2008. They discuss how the period of the 1970's weighed heavily on the American zeitgeist and the political transformation that occurred between the start of the Iran hostage crisis and the fall of the Berlin Wall. The episode culminates in a conversation about the political and monetary forces that have been unleashed in response to the spread of COVID-19 and their implications for the future of capitalism and liberal democracy.

    submitted by /u/cpclos
    [link] [comments]

    I think tech is the new gold and that’s pumping the market

    Posted: 11 May 2020 09:22 AM PDT

    Think about it. If you hade billions of dollars and little faith in the economy, where would you put it? Gold? It's near ATHs so the potential for loss is high. Bonds? At these rates? Cash? With infinite QE happening inflation could be a real concern. No it's tech. Tech has performed very well over the past 20 years and many tech companies are minimally affected by the current environment. Some even benefit. What's more tech has some of the biggest most stable companies there are with plenty of cash on hand to weather a storm. So tech seems like a safe bet.

    If I'm right tech is acting as a safe place to stash billions of dollars. Because the S&P and the NASDAQ are disproportionately made up by large tech firms, and because those are seen as the best indicators for the broader market, this makes the broader market look better than it should. It's giving people a false sense of confidence in the market as a whole.

    What happens if the smart money no longer feels like tech is the safest place to store their money? The bottom falls out. What happens when mainstreet actually starts to recover? Billions of dollars flow out of tech and into other sectors. Much of it may go to small cap stocks. So when the economy actually starts improving, the S&P and Nasdaq may crater.

    I will freely admit that I am an amateur with limited experience. So if someone with more knowledge on the subject, especially bonds, wants to correct me or tell me why I'm wrong, feel free. I'm hoping this will start a discussion.

    submitted by /u/jckonln
    [link] [comments]

    Skeptical about the Tech Market

    Posted: 11 May 2020 08:18 AM PDT

    I can't seem to rationalize why tech stocks are continuing to climb as high as they are. I know their earnings aren't in the tank like most other sectors, but the P/E ratios for a lot of theses companies is insane. Surely the growth will level off?

    submitted by /u/cswest1
    [link] [comments]

    Hedge Fund Billionaire Michael Platt

    Posted: 11 May 2020 08:38 AM PDT

    In 2015, Michael Platt decided to go it alone and close his hedge fund BlueCrest Capital Management to clients.

    BlueCrest had been one of the biggest hedge funds in Europe, with $37 billion of assets under management.

    However, after a few years of disappointing returns, investors became less enamoured with Platt.

    One issue they focused on was a proprietary BlueCrest fund that only managed Platt's capital and money belonging to other BlueCrest partners and employees.

    As well as this, institutional investors were pushing for lower fees.

    Hedge funds typically follow a "2 and 20" model: Investors pay an annual management fee of 2 percent of assets under management and 20 percent of profits.

    According to Platt, "It's much more profitable to have 0 and 100 rather than 2 and 20,"

    This refers to the fact that they don't need to share profits with outside investors.

    So in 2015 Platt returned the $7 billion BlueCrest managed for outside clients and decided to turn BlueCrest into a private investment partnership and focus on managing his own wealth and that of his partners and employees.

    This decision has certainly paid off handsomely for Platt and BlueCrest.

    Since 2015 he has more than doubled his net worth - which currently sits at $8 billion.

    In 2019, BlueCrest returned 53.5% net after expenses and Platt made about $2 billion.

    With a much smaller asset base, Platt has increased leverage, took on more risk, and enjoyed strong returns.

    The majority of BlueCrest's returns did not come from trading equities, which surged last year, but from significant long fixed income positions early in 2019.

    Platt first became involved in the markets through his grandmother.

    "She was a long-term investor and did very well at it. She was a very strong woman. She wasn't interested in baking cake for me; she was interested in what stock I wanted to buy or sell."

    Platt states that he has had a very easy life because he never had to think about what he wanted to do:

    He wanted to be a trader from the age of 12 and started when he was 13, successfully trading stocks through high school and university with one major exception - the infamous Black Monday Crash of 1987, when his stock account lost half its value in a single day.

    Platt has no tolerance for trading losses:

    "I hate losing money more than anything. Losing money is what kills you. It is not the actual loss. It's the fact that it messes up your psychology."

    Platt believes in aggressive stop losses and effectively structures his traders like they are options

    He will cut trader's allocations by half if lose 3% of their capital and remove their capital allocation if they lose more than 6%.

    However, he will also lift allocations to winning trades - therefore the downside is limited, but the upside is unlimited.

    "We want people to scale down if they are getting it wrong and scale up if they are getting it right. If a guy has a $100 million allocation and makes $20 million, he then has $23 million to his stop point."

    But what does Platt looks for in his traders?

    Someone who has an edge:

    "I look for the type of guy in London who gets up at seven o'clock on Sunday morning when his kids are still in bed, and logs onto a poker site so that he can pick off the U.S. drunks coming home on Saturday night. I hired a guy like that. He usually clears 5 or 10 grand every Sunday morning before breakfast taking out the drunks playing poker because they're not very good at it, but their confidence has gone up a lot."

    Paranoia:

    "I want guys who when they put on a good trade immediately start thinking about what they could put on against it. They just have the paranoia."

    The market is always right:

    "Market makers know that the market is always right. They know value is irrelevant in times of market stress; it's all about positions. They understand that markets will trade against positions. They get it."

    Someone who admits they are wrong:

    "Both the ex-market makers who blew up became way too invested in their positions. Their ego got in the way. They just didn't want to be wrong, and they stayed in their positions."

    Recently, it was reported that BlueCrest cut at least 10 portfolio managers as the firm suffered losses in its fixed-income relative value strategy.

    It also cut risk across the firm by about $1 billion.

    Relative-value trades involve trying to profit from small differences in the prices of similar assets, such as two different Treasury bonds or a bond versus a future.

    To boost profitability, portfolio mangers tend to employ substantial leverage.

    Therefore, they rely on the steady availability of financing and a relatively stable relationship between the securities in the portfolio. This means that, when volatility increases sharply, losses can mount very quickly.

    While BlueCrest suffered some losses since the sell-off, they are apparently still up for the year.

    Over the 15 years that BlueCrest managed client money, they produced more than $22 billion in trading profits for investors.

    It's not quite the insane returns of the GOAT hedge fund, Renaissance Technologies' Medallion fund, but nonetheless still pretty good.

    Since becoming a private investment partnership in 2015, the returns have been sensational.

    2016: 50%

    2017: 54%

    2018: 25%

    2019: 53.5%

    https://www.youtube.com/watch?v=KCD1egPq170

    submitted by /u/financeoptimum
    [link] [comments]

    Intrigued by VTIQ (soon to be NKLA)

    Posted: 10 May 2020 11:17 PM PDT

    Reading deep into Nikola, I'm pretty intrigued by their stock and their future. Seems like a well run company with solid financials, a product the world needs for the future and already $14 billion (their claim) in revenue of preordered trucks with even more demand.

    With NKLA coming on the market soon, what are your thoughts on buying VTIQ now? Why not? Why would you wait? I'm not experienced in buying mergers.

    Trucking company stocks range from $24 (Navistar) to $69 (PACCAR). The stars seem to be aligning for this to be the next Titan of the industry.

    submitted by /u/RonnieKRadio
    [link] [comments]

    The Lack of Rebound in Banks

    Posted: 11 May 2020 07:58 AM PDT

    I understand people being bullish and I understand people being bearish

    What I'm having a hard time understanding is the overwhelmingly bearish sentiment in banking and the highly bullish sentiment in tech. Several companies on the Nasdaq are at or near ATHs and the Nasdaq is famously up on the year. All the while the banking sector of the S&P is down 38% YTD. And it's not a wide disbursement between them where the best are recovering. Most banks are still very much beaten down from their 52 week highs. They are widely underperforming the broad S&P by almost 30% year to date.

    So this got me to thinking, how does this scenario play out? The banks put up reserves in 1Q in order to reserve for adverse loan performance expected in 2Q. Based on market reaction, I can only think people believe that actual performance will be worse than expected (since banks like JPM were able to still have positive earnings in 1Q even after shaving off a significant portion for reserves).

    So what scenario exists where defaults absolutely swamp the banks to the degree that they are throwing off significant losses and revenues of all these tech companies is fine? I view the banks as a pretty integral part of the economy's health. If you have massive loan defaults, how is this not going to impact the entire economy?

    TLDR; Been looking at leaps on banks, someone talk me out of it

    submitted by /u/The_Masked_Contango
    [link] [comments]

    new trader

    Posted: 11 May 2020 09:51 AM PDT

    hello all hope everyone is doing well,

    I apologize if I am not posting in the right are but I am interested in getting involved with the stock market and trading, but im not sure what program to use or where to start. I am in Canada(Ontario more specifically) and most youtube videos have recommended to use td. they charge a 10 fee per trade or something and I have no experience so im looking for something smaller. does any one have any recommendations on how to start and where to start

    If someone could help me out that would be great thanks

    submitted by /u/Conscious_Paramedic
    [link] [comments]

    Why can't I just sink all my cash into the top high risk picks for 2020?!

    Posted: 11 May 2020 07:28 PM PDT

    I guess one can say I'm new to investing as I'm still in college and only have a few hundred invested in stocks, from which they are 'safe stocks' as a friend advised I be safe(he's fresh out of college with a finance major). My problem with all these finance people is they make it sound so complicated when you're picking a stock. Isn't it just a quick google search of "the best stocks of 2020", then pick a few randoms and call it a day? I just googled "the best high-risk stocks of 2020" and the first article that popped up was written a little over two months ago. The picks consist of three different companies: Ediates medicine, Puma biotechnology, and Xenon pharmaceuticals. So then I googled how each has done and here are the results based on if you bought a month ago(remember, this article was posted over two months ago). One company went from $22 a share to $27. another went from $8 a share to $13, and the last went from $12 a share to $13.

    I'm sharing these numbers because the proof is in the pudding!! I will be graduating soon with a great degree and won't be in debt a single penny, so let's say I make 40k a year after taxes, why not just invest all of it equally in these three stocks? The would-be insane earnings!! And yes, I am willing to risk 40k...I'm not a 'chicken little'.

    submitted by /u/BedWetter1000
    [link] [comments]

    Without retail...it's all gonna be online shopping?

    Posted: 11 May 2020 09:33 AM PDT

    Sears, Penneys, Macys, Neiman Marcus...so many retailers are dying. Are people really just keep their fat lazy asses at home and shopping on Amazon? Walmart clothing sucks...Ross sucks...

    submitted by /u/KnightAnthony
    [link] [comments]

    New to trading

    Posted: 11 May 2020 04:50 PM PDT

    Hi everyone. new to trading and I have a Q. Iv been playing with penny stocks but haven't seen much gains. If any. Do you think the profit margins are are greater with stocks valued at $10 or greater? Or penny stocks?

    submitted by /u/Livi7
    [link] [comments]

    Risk of Ruin - Doomed to Failure

    Posted: 11 May 2020 09:16 AM PDT

    I am new to trading, and after some backtest, I was trying to calculate the risk of Ruin. The formula goes like:

    R=[(1-A)/(1+A)]c

    R: probability of Ruin A:The difference between the percentages of wining trades and the percentage of losing trades. c: the number of trades in a account

    Now it seems that by using that formula, if you have a winning percentage below 50% you are always doomed to failure, am I correct? I'm using a trading system with about just 20% winning rate but a R/R of at least 12, sometimes going to 50...

    submitted by /u/Goddamn_Name
    [link] [comments]

    Institutions

    Posted: 11 May 2020 05:22 AM PDT

    Institutions

    Institutions control the overwhelming majority of the power to sway the markets. Blue chip companies - check who hold their largest voting blocs - it's the institutions: BlackRock, Vanguard, et al. Who controls the ETFs? The pension funds that the peasants store their measly savings in? The same old boys' club. It is they who set the share prices, period.

    Everyone talks about how it's FOMO that's driving prices up the wall. But because they aren't allowed to, no one ever talks about the puppet masters behind the scenes. Yes, maybe the retail trade sector has some nominal influence to an extent but the real clout is held by the big guns. AND the exchanges that the populace punt on. That's why, if you'll notice, the markets move in almost perfect lockstep. They move these massive blocks at the precise time of their choosing. No one ever talks about how the institutions know exactly where the market is going at any given point in time not because they can predict the future but because they are the ones that manipulate it and set the prices.

    Who came out and called the bottom after the smoke cleared and the dust settled? Larry Fink who advises Trump and heads BlackRock, a firm that has been tasked by the Fed to run several stimulus programmes, and strategists' at Goldman Sachs, among others. Rick Rieder, also of BlackRock, sits on a committee of the New York Fed. The lion's share of the newly printed stimulus trillions is flooding into their coffers and washing out all the bad debt. Voila, their books are squeaky clean all of a sudden. Where do they pour this fresh cash? Into the markets, inflating it and thereby locking out everyone else.

    In this thinly-veiled vulgar display of crony capitalism, they have flaunted that they will never be held accountable and thus the same tired behaviour will continue ad infinitum, and the next decade/s-long bull market will no doubt be a repeat of the infantile card pyramid debt-stacking that we've all seen eventually fall over and over, time and time again, the mess promptly swept under the rug by Uncle Sam in a mammy apron.

    Meanwhile, stimulus for main street and the working class quickly runs out, having been reduced to sloppy seconds by the ruling class who must always have their fill first, yields of anything other than equities, and maybe gold, are negative or at best infinitesimal, market valuations are at exorbitant and hardly-justifiable all-time highs, and the commonfolk are once again caught holding the bag with a quickly-sinking economy, ever-increasing and never-before-seen levels of unemployment and rapidly-rotting debt, and of course, the piece-de-resistance, the cherry on the creampie, a horrendously-manhandled health crisis, haphazardly steered by a drunk driver who's only destination is reelection, passengers' destination be damned.

    Needless to say, with election season swiftly approaching, Trump, with a fire under his ass, has persisted to vigorously whip JPow's already-red-raw booty, to get him to crank that printer ever faster in an explosion of meaningless paper.

    submitted by /u/TonyDarkSky
    [link] [comments]

    Invested in 6 companies - what's next?

    Posted: 11 May 2020 05:21 AM PDT

    Hi guys,

    About a month and a half back I figured out it's about time I begin investing since I'm 26.
    Encouraged by using Revolut as my financial management instrument I bought a bunch of stocks and have driven minor analysis. Decisions that I have made are based on two factors:

    1. Products that I am personally using + a lot of buzz among my millenial friends.
    2. Reading charts + checking most recent news.

    Within a month and a half I have built a portfolio of 6 different companies and my picks were:

    ETSY -> up 52.96% to date

    BYND -> up 62.67% to date

    UBER -> up 54.78% to date

    HLTN -> up 14.81% to date

    NPTN -> up 9.7% to date

    GRPN -> down 14.07% to date

    Overall my portfolio is up 30%. How do I keep growing from that point? I really would like to make sure my portfolio is well maintained but I don't want to make it my daily obsession. I would really like to make it as passive as possible while keeping my portfolio healthy. Should I sell some of the stocks sometimes? Should I keep on investing in the ones that I currently have - if so when is the right time? How to best manage what I currently have?

    Thanks a lot in advance for your help, and wish all the best to everyone on the journey to secure their future.

    submitted by /u/shadybron
    [link] [comments]

    AMC & AMZN.. Buy the rumour?

    Posted: 11 May 2020 12:26 PM PDT

    Is This the right strategy boys?

    Posted: 11 May 2020 12:07 PM PDT

    I am only 20% invested in this market. The other 80% are in cash in my brokerage account waiting for a drop.

    I am only 20% invested, because I think that the market is retarded

    I am 80% out until I see a big drop in the market (where I buy), or there is a clear breakthrough in the vaccine and positive economic data AND only then i'll invest my remaining 80%

    My Current Holdings are:

    JPM / AXP / MS / ABBV / MRK / GILD / WMT / AMZN / LHE.DE (this on is risky)

    I am pretty much investing in financials because they are at fairly low prices (compared to other sectors)

    And then my next holdings are the recession proof ones (Healthcare and Retail)

    My Lufthansa Position is more like gambling

    What do you guys think ???? Any suggestions ???

    submitted by /u/ZZZ_Radezzz_ZZZ
    [link] [comments]

    What is your opinion about cruise lines business? E.g. Carnival, Royal Caribbean etc

    Posted: 11 May 2020 11:57 AM PDT

    Some announced that lines will be opened again coming August, on the other end Norwegian Cruise Line had a warning of possible bankruptcy. Cruise lines Stocks are now traded about 60-80% below their yearly average. Of course no one knows what will happen. But what is your general feeling?

    Opportunity or stay away?

    https://www.dailymail.co.uk/news/article-8307487/Carnival-Cruise-bookings-600-PERCENT-announcing-voyages-restart-August.html

    https://www.forbes.com/sites/sergeiklebnikov/2020/05/06/norwegian-cruise-line-raises-over-2-billion-after-warning-of-possible-bankruptcy/#c311522b8716

    https://finance.yahoo.com/quote/CCL?p=CCL $CCL

    https://finance.yahoo.com/quote/RCL?p=RCL $RCL

    submitted by /u/guyromb
    [link] [comments]

    NEXCF - Gaining momentum

    Posted: 11 May 2020 10:02 AM PDT

    NEXCF - Nextech AR Solutions

    Nice gains to start the week off -- earning report also coming this week...

    Link: https://stockdaymedia.com/nextech-to-release-q1-earnings-on-may-14th-2020/

    submitted by /u/greg_718
    [link] [comments]

    No comments:

    Post a Comment